GE HealthCare Technologies (NASDAQ:GEHC) reported Q2 adjusted earnings of $0.92 per diluted share, down from $1.15 a year earlier.
Analysts polled by Capital IQ expected $0.87.
Revenue for the quarter ended June 30 was $4.82 billion, compared with $4.48 billion a year ago.
Analysts surveyed by Capital IQ expected $4.79 billion.
The company said it expects full-year 2023 adjusted earnings of $3.70 to $3.85 per diluted share, compared with $3.60 to $3.75 anticipated previously. Analysts polled by Capital IQ expect $3.74.